The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

A phase I/II study of enzalutamide in combination with indomethacin in men with castration-resistant prostate cancer (CRPC).

Ryan  Leibrandt

No Relationships to Disclose

Ayman Teeham  Ullah

No Relationships to Disclose

Rashmi  Verma

No Relationships to Disclose

Allen  Gao

Stock and Other Ownership Interests  - Pandomedx

Primo N.  Lara

Research Funding - AstraZeneca (Inst); Taiho Pharmaceutical (Inst)

Chong-xian  Pan

Stock and Other Ownership Interests  - Accelerated Medical Diagnostics; LP Therapeutics; Pandomedx

Mamta  Parikh

Consulting or Advisory Role - Bristol Myers Squibb; Natera; Pfizer-Myovant; Sanofi/Aventis

Research Funding - Gilead Sciences; Karyopharm Therapeutics